Lateral Occlusion of Uterine Artery in Total Laparoscopic Hysterectomy

Status Recruiting

Clinical Trial Summary

Laparoscopic hysterectomy is associated with complications in form of infections and subsequently dehiscence of the vault. This is a serious complication. The infection may be related to the frequently observed postoperative hematoma following traditional laparoscopic hysterectomy where the uterine artery is coagulated and divided at the cervical entry into the uterus.

By coagulation of the uterine artery laterally close to the internal iliac artery this problem may be eliminated due to the much less bleeding observed during this procedure.

Clinical Trial Description

Laparoscopic hysterectomy (removal of the uterus) is today a well-described method for the removal of the uterus. The operation is offered in case of bleeding disorders where other treatments have been unsuccessful, uterine fibroids or other conditions requiring surgery with removal of the uterus.

The operation is done today in most cases by dividing the uterine artery at the entrance to the cervix, where the artery divides into one ascending and descending branch.

The most common complication of hysterectomy is bleeding perioperative well as postoperatively, which may result in a hematoma above the vaginal vault.

Through the years different methods have been tried to reduce this complication, including tranexamic acid without great success. The hematoma may result in infection postoperative and subsequent poor healing, with the possibility of dehiscence of the vault.

In the worst case, the gut is displaced through the vagina postoperatively. This condition can lead to diffuse peritonitis, which can be fatal in rare cases.

Since the hemostasis related to the dividing of the artery uterine can be problematic, especially in case of fibroids it may be a technical advantage to coagulate the Uterine artery at the exit of the Internal Iliac artery. This operation also ensures identification of the ureter, which can be spared. Lesions to the ureter are detected in up to 1% of all surgical procedures at hysterectomy.

Dividing of the Uterine artery at the Internal Iliac Artery also ensures that the artery can be divided with minimal bleeding at the cervix. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02709460
Study type	Interventional
Source	Odense University Hospital
Contact	Vibeke Lysdal, Consultant
Phone	+4560113333
Email	mr@rsyd.dk
Status	Recruiting
Phase	N/A
Start date	January 2016
Completion date	December 1, 2019

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02963623` - Fibtem Predicts Postoperative Bleeding	N/A
Completed	`NCT00307138` - Hetastarch and Bleeding Complications After Off-Pump Coronary Bypass Surgery	Phase 3
Active, not recruiting	`NCT06114758` - Comparison Effectiveness of Rectal Misoprostol & Intravenous Tranexamic Acid Reducing Hemorrhage in Myomectomy
Completed	`NCT03793816` - Tonsillectomy Using BiZact™ - a Randomized Side-controlled Clinical Trial	N/A
Terminated	`NCT05308589` - CPPF After General Cardiac Surgery	N/A
Completed	`NCT04505475` - Oral Surgery in Patients Taking Direct Oral Anticoagulants
Completed	`NCT05229276` - Efficacy of Sternum Guard in Post Cardiac Surgery Patient	N/A
Completed	`NCT05817474` - Efficacy of Local Infiltration of Tranexamic Acid and Lidocaine in Tonsillar Bed on Postoperative Bleeding and Pain During Tonsillectomy Surgery: Prospective, Randomized, Control Study	N/A
Terminated	`NCT02343263` - Effect of Bupivacaine-infused Fibrin Sealant Application on Post-tonsillectomy Pain & Hemorrhage	Phase 2
Not yet recruiting	`NCT06285656` - Femoral Blood Gas and Prediction of Postoperative Bleeding
Recruiting	`NCT04725305` - BiZact Tonsillectomy in the Pediatric Population	N/A
Recruiting	`NCT01889732` - A Gray Zone Approach of Rotational Thromboelastometry for Predicting Postoperative Bleeding in Cardiac Surgical Patients	N/A
Completed	`NCT00337766` - Desmopressin in Cardiac Surgery	Phase 4
Completed	`NCT00587444` - Optimal Heparin Dosing Regimens for Cardiopulmonary Bypass	Phase 3
Completed	`NCT06238739` - Optimal Temperature Control in Body Contouring Procedures	N/A
Terminated	`NCT02358850` - Post-tonsillectomy Pain Control in Adults	Phase 4
Completed	`NCT02627560` - The Effect of Topical Tranexamic Acid on Bleeding and Seroma Formation in After Undergoing Mastectomy	Phase 4
Completed	`NCT03244423` - Tranexamic Acid in Cyanotic Heart Defects	Phase 2
Completed	`NCT00597363` - Neptune Pad ® Compared to Conventional Manual Compression	N/A
Recruiting	`NCT05206799` - The CMCPCTH Research in Chinese Children

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.